
zzso agents zzso used for the treatment of zzso anemia in cancer patients have been associated with adverse outcomes of enhanced tumor progression and impaired survival in a series of recent clinical zzso As clinical practice guidelines for zzso administration in cancer patients have evolved to improve safety, the mechanisms underlying the adverse outcomes and whether zzso exert direct and/or indirect effects in primary tumors to zzso tumor cell growth, survival, and zzso responses remain zzso zzso zzso zzso expression in tumor cells has raised the simplistic possibility that zzso signaling zzso via a functional cellular zzso may contribute to tumor progression in a direct zzso However, zzso biology in cancer is likely to be complex and an interplay of multiple factors is potentially involved in the overall tumor response to zzso zzso zzso of zzso use as an important supportive therapy zzso in cancer patients, and further investigation of the role of zzso in cancer biology will require a combination of carefully designed zzso and clinical studies designed to ascertain not only the effect of zzso therapy on clinical outcomes such as tumor response, zzso and overall survival but also to investigate the potential effects of zzso on zzso of zzso zzso and factors related to tumor biology and zzso zzso 

